商品分類

瀏覽歷史

B21177	薯蕷皂苷元
源葉	分析標(biāo)準(zhǔn)品,HPLC≥98%

英文名：
Diosgenin

別名：
薯蕷皂素;地奧配質(zhì)

CAS號(hào)：
512-04-9

分子式：
C₂₇H₄₂O₃

分子量：
414.61

MDL：
MFCD00016887

核磁/質(zhì)譜：

品牌	貨號(hào)	產(chǎn)品規(guī)格	價(jià)格(RMB)	庫(kù)存（上海）	北京	武漢	南京	計(jì)量單位	加入購(gòu)物車...
源葉	B21177-20mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥50.00元	>10	1	5	4	EA	加入購(gòu)物車
源葉	B21177-50mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥110.00元	>10	-	-	-	EA	加入購(gòu)物車
源葉	B21177-100mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥180.00元	>10	-	-	-	EA	加入購(gòu)物車
源葉	B21177-200mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥300.00元	>10	-	-	-	EA	加入購(gòu)物車

大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》，到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(36篇)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

介紹：
藥理藥效：薯蕷皂素是一種植物類固醇,誘導(dǎo)結(jié)腸癌細(xì)胞凋亡和誘導(dǎo)骨肉瘤細(xì)胞凋亡，細(xì)胞周期阻滯和COX活性。

熔點(diǎn)： 205-208°C

沸點(diǎn)： 527.1 °C at 760 mmHg

比旋光度： D25 -129° (c = 1.4 in CHCl3)

外觀：白色至淡黃色片狀或針狀結(jié)晶

溶解性：二氯甲烷：5mg/ml（需超聲）
乙醇：1mg/ml（需超聲）
DMSO：基本不溶
HPLC檢測(cè)建議用二氯甲烷溶解后再用甲醇稀釋，純甲醇溶解性不好。

儲(chǔ)存條件： 2-8℃

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

36. [8.5] Jing Pan et al."Bioactivity and application potential of O/W emulsions derived from carboxylic acid-based NADES-extracted total saponins from Polygonatum cyrtonema Hua."FOOD CHEMISTRY.2025 Jan;463:141363

35. [4.2] Decheng Meng et al."Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway."EUROPEAN JOURNAL OF PHARMACOLOGY.2024 Aug;977:176737

34. [4.8] Wenfei Yu et al."Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway."INTERNATIONAL IMMUNOPHARMACOLOGY.2024 Sep;138:112581

33. [IF=4.7] Xinyu Li et al."Gut microbiota modification by diosgenin mediates antiepileptic effects in a mouse model of epilepsy."JOURNAL OF NEUROCHEMISTRY.2023 Dec;:

32. [IF=7.3] Rui-Fang Dong et al."Discovery of a potent inhibitor of chaperone-mediated autophagy that targets the HSC70-LAMP2A interaction in non-small cell lung cancer therapy."BRITISH JOURNAL OF PHARMACOLOGY.2023 Jun;:

31. [IF=5.195] Suwen Chen et al."Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway."EUROPEAN JOURNAL OF PHARMACOLOGY.2023 Aug;952:175808

30. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

29. [IF=6.525] Lixia Chen et al."A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy."Pharmaceutics.2022 Aug;14(8):1685

28. [IF=6.417] Chen Zhou et al."22R- but not 22S-hydroxycholesterol is recruited for diosgenin biosynthesis."Plant Journal. 2021 Dec 07

27. [IF=5.753] Jianghong Gao et al."Molecular Cloning and Functional Characterization of a Sterol 3-O-Glucosyltransferase Involved in Biosynthesis of Steroidal Saponins in Trigonella foenum-graecum.."Front Plant Sci. 2021 Dec;12:809579-809579

26. [IF=3.645] Shuo Gu et al."Develop a stepwise integrated method to screen biomarkers of Baihe-Dihuang Tang on the treatment of depression in rats applying with composition screened, untargeted, and targeted metabolomics analysis."Journal Of Separation Science. 2022 M

25. [IF=2.289] Zhou Shun et al."Anthelmintic efficacy of natural saponins against Gyrodactylus kobayashii in goldfish (Carassius auratus) and their 3D-QSAR analysis."Parasitol Res. 2021 Mar;120(3):1143-1150

24. [IF=3.998] Chengfei Zhang et al."Transcriptome analysis of the effect of diosgenin on autoimmune thyroiditis in a rat model."Sci Rep-Uk. 2021 Mar;11(1):1-12

23. [IF=4.242] Shun Zhou et al."Anthelmintic efficacy of 35 herbal medicines against a monogenean parasite, Gyrodactylus kobayashii, infecting goldfish (Carassius auratus)."Aquaculture. 2020 May;521:734992

22. [IF=5.275] Liangqun Li et al."Microbial transformation of diosgenin to diosgenone by Wickerhamomyces anomalus JQ-1 obtained from Naxi traditional Jiu Qu."Bioorg Chem. 2020 Jan;95:103508

21. [IF=5.923] Lixiu Hou et al."Genome-Wide Identification of CYP72A Gene Family and Expression Patterns Related to Jasmonic Acid Treatment and Steroidal Saponin Accumulation in Dioscorea zingiberensis."Int J Mol Sci. 2021 Jan;22(20):10953

20. [IF=0.533] P Wang et al."Ionic Liquid-Based Ultrasonic/Microwave-Assisted Extraction of Steroidal Saponins from Dioscorea zingiberensis C. H. Wright."Trop J Pharm Res. 2014 Sep;13(8):1339-1345

19. [IF=2.998] Lei Lei et al."Preparation of diosgenin from Dioscorea zingiberensis C. H. Wright by stepwise biocatalysis-foam separation-preparative high-performance liquid chromatography (P-HPLC)."Eur Food Res Technol. 2018 Aug;244(8):1447-1452

18. [IF=4.759] Mengshun Liu et al."Folding fan mode counter-current chromatography offers fast blind screening for drug discovery. Case study: Finding anti-enterovirus 71 agents from Anemarrhena asphodeloides."J Chromatogr A. 2014 Nov;1368:116

17. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466

16. [IF=9.297] Peng Wang et al."Conversion of steroid saponins into diosgenin by catalytic hydrolysis using acid-functionalized ionic liquid under microwave irradiation."J Clean Prod. 2014 Sep;79:265

15. Wang, Peng, et al. "Conversion of steroid saponins into diosgenin by catalytic hydrolysis using acid-functionalized ionic liquid under microwave irradiation." Journal of cleaner production 79 (2014): 265-270.https://doi.org/10.1016/j.jclepro.2014.05.041

14. 李慧敏,鄭淘,曾藝瓊,范郁冰,李衛(wèi)真,嚴(yán)建業(yè),趙利平,鄭慧,楊勇.AHP-CRITIC權(quán)重分析法綜合優(yōu)選玉竹全粉改性工藝[J].食品與發(fā)酵工業(yè),2021,47(05):138-146.

13. 胡佳莉. 紅曲黃精發(fā)酵工藝及免疫調(diào)節(jié)和降血脂作用研究[D].廣東藥科大學(xué),2020.

12. 周曉,李婧琳,鄒俊波,張小飛,郭東艷,程江雪,史亞軍,石心紅,賈曉斌.粒子設(shè)計(jì)對(duì)參苓白術(shù)散在大鼠體內(nèi)藥動(dòng)學(xué)過程的影響[J].中草藥,2020,51(19):4925-4933.

11. 石鴻輝苑廣偉廖正睿等. 不同菌種發(fā)酵對(duì)辣木莖葉粉的營(yíng)養(yǎng)價(jià)值及其抗氧化活性的影響[J]. 食品工業(yè)科技 2019 040(009):91-97 104.

10. 張澤銳, 黃申, 劉京晶,等. 多花黃精和長(zhǎng)梗黃精花主要營(yíng)養(yǎng)功效成分[J]. 中國(guó)中藥雜志, 2020, v.45(06):123-127.

9. 楊亞利劉佳張鵬等. 4種重樓不同部位薯蕷皂苷及皂苷元含量的分析[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥 2016(5):1035-1038.

8. 胡佳莉, 劉林, 李鐘,等. 黃精發(fā)酵過程中有效成分含量與色澤的相關(guān)性[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2020(15).

7. 陳振興,趙瑞芝.薯蕷皂苷元對(duì)鹽酸米托蒽醌誘導(dǎo)耐藥子宮肉瘤細(xì)胞MES-SA/MX2凋亡的增敏作用[J].中國(guó)藥學(xué)雜志,2017,52(24):2157-2160.

6. 孫蕊, 牛潔, 曹芳,等. 薯蕷皂苷元對(duì)LPS誘導(dǎo)的人胚肺成纖維細(xì)胞的干預(yù)機(jī)制研究[J]. 環(huán)球中醫(yī)藥, 2019, 012(007):988-993.

5. 趙楊, 曾禾鑫, 成志強(qiáng),等. 鹽蒺藜的制備及質(zhì)量控制研究[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥, 2019, v.30;No.288(08):98-100.

4. 李會(huì), 張佳佳, 梁靜怡,等. 基于酶法輔提和微波酸解的黃姜薯蕷皂苷元清潔生產(chǎn)工藝[J]. 食品科學(xué), 2012, 033(020):94-98.

3. 袁志鷹, 羅林明, 陳乃宏,等. 基于UPLC-Q-TOF-MS法分析百合珠芽化學(xué)成分及其薯蕷皂苷元抗腫瘤活性研究[J]. 天然產(chǎn)物研究與開發(fā), 2019, 31(05):808-813.

2. 楊南南李會(huì) 吳燕張曉梅許正宏史勁松.Gibberella intermedia WX12產(chǎn)特異性糖苷酶的發(fā)酵工藝優(yōu)化[J].食品與生物技術(shù)學(xué)報(bào) 2016 35(10):1028-1034.

1. 趙麗蓉羅漢相英龍等. Box-Benhken響應(yīng)面法優(yōu)化微波提取黃精總皂苷的條件[J]. 中國(guó)現(xiàn)代中藥 2018 20(008):1010-1015.